The ovarian cancer market was valued at USD 3.60 Billion in 2024, driven by the increasing prevalence of ovarian cancer across the 8 major markets. The market is expected to grow at a CAGR of 6.60% during the forecast period of 2025-2034, with the values likely to reach USD 6.82 Billion by 2034.
Base Year
Historical Year
Forecast Year
The rising burden of ovarian cancer is driving the market demand for advanced treatment options.
The shift towards personalized medicine and increased focus on early detection of ovarian cancer are significant market trends.
Increased investment in oncology research and development, rising adoption of combination therapies, and a supportive regulatory environment are impacting the market landscape.
Value in USD Billion
2025-2034
Ovarian Cancer Market Outlook
*this image is indicative*
Ovarian cancer refers to cancerous growth in the ovaries. It usually develops in women aged 50 or above. Ovarian cancer often shows no symptoms during the early stages. The rising incidence of ovarian cancer is driving the development of advanced treatment options. Improvements in diagnostic technologies are facilitating early and accurate detection of ovarian cancer, which is likely to aid market growth. The growing research into new targeted therapies and combination treatments is expected to expand the treatment alternatives available for ovarian cancer patients, further boosting the market demand. Heightened awareness about ovarian cancer, increasing investment in oncology research and development, and advancement in healthcare infrastructure, particularly in developing countries, are some of the factors influencing the market dynamics.
Increasing Prevalence of Ovarian Cancer to Bolster Market Growth
Ov arian cancer ranks as the fifth leading cause of cancer-related mortality among women. It is reported as the 11th most common cancer among women, accounting for 2.5% of cancers in women. According to the American Cancer Society, around 19,680 new cases of ovarian cancer are estimated to be diagnosed in 2024 and about 12,740 women are predicted to die of this cancer in the United States. The increasing burden of ovarian cancer is a primary driver of the market, propelling the demand for safe and effective therapies.
The market is witnessing several trends and developments to improve the current scenario across the 8 major markets. Some of the notable trends are as follows:
Market Breakup by Treatment Type
Market Breakup by Cancer Type
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Treatment Type Holds a Significant Market Share
Based on the treatment type, the market is segmented into chemotherapy, immunotherapy, surgery, radiation therapy, targeted drug therapy, and others. Chemotherapy is one of the most common treatment options for ovarian cancer which involves the use of medications to kill or slow the growth of cancer cells. The targeted drug therapy segment is expected to hold a significant market share in the forecast period due to its ability to target cancer cells while reducing damage to healthy tissues. The rising advancements in molecular biology and the growing demand for personalized medicine are likely to bolster the growth of this segment in the forecast period.
Based on the region, the market includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States represents a major share of the market owing to the high healthcare expenditure and the presence of key pharmaceutical companies. Robust research efforts and government initiatives to support cancer research are some of the factors aiding the market growth in the region. Further, the market in India is expected to expand rapidly due to growing healthcare awareness and improvement in medical infrastructure. The rising prevalence of ovarian cancer and the increasing adoption of advanced treatments are likely to further boost the market growth in the country.
The key features of the market report comprise patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
AstraZeneca plc, headquartered in England, United Kingdom, is a British-Swedish multinational pharmaceutical and biotechnology company with a prominent presence in the market. The company's key product Lynparza is a PARP (poly ADP ribose polymerase) inhibitor prescribed for the treatment of advanced ovarian cancer in adults.
Pfizer, Inc., an American multinational pharmaceutical industry company, is one of the leading players in the market. The company has a robust oncology pipeline, with several ongoing clinical trials aimed at expanding the use of its drugs in ovarian cancer and other cancers.
Swiss multinational pharmaceutical corporation Novartis AG is significantly contributing to the market growth by making strategic investments in targeted therapies and immuno-oncology. The company is engaged in exploring drug combinations and next-generation therapies that could effectively treat ovarian cancer. Novartis is also involved in acquisitions and partnerships to expand its oncology portfolio.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Amgen Inc., Bristol-Myers Squibb Company, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., AbbVie Inc., and GSK plc., among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Cancer Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share